131 related articles for article (PubMed ID: 14766269)
1. Concurrent ovarian-type primary peritoneal adenocarcinoma and peritoneal choriocarcinoma. A case report and review of the literature.
Pentheroudakis G; White J; Davis J; Brown I; Vasey P
Gynecol Oncol; 2004 Feb; 92(2):697-700. PubMed ID: 14766269
[TBL] [Abstract][Full Text] [Related]
2. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
3. Pure nongestational choriocarcinoma of the ovary: a case report.
Choi YJ; Chun KY; Kim YW; Ro DY
World J Surg Oncol; 2013 Jan; 11():7. PubMed ID: 23320455
[TBL] [Abstract][Full Text] [Related]
4. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY
Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142
[TBL] [Abstract][Full Text] [Related]
5. Good prognosis for primary ovarian pure nongestational choriocarcinoma using the EMA/CO regime.
Ozturk E; Ugur MG; Cebesoy FB; Aydin A; Sever T; Balat O
Eur J Gynaecol Oncol; 2010; 31(1):123-5. PubMed ID: 20349799
[TBL] [Abstract][Full Text] [Related]
6. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
[TBL] [Abstract][Full Text] [Related]
7. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
8. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
Covens A; Blessing J; Bender D; Mannel R; Morgan M;
Gynecol Oncol; 2006 Mar; 100(3):586-90. PubMed ID: 16249022
[TBL] [Abstract][Full Text] [Related]
9. Ovarian clear cell carcinoma with choriocarcinomatous differentiation: report of a rare and aggressive tumor.
Hu YJ; Ip PP; Chan KK; Tam KF; Ngan HY
Int J Gynecol Pathol; 2010 Nov; 29(6):539-45. PubMed ID: 20881859
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer.
Gordon AN; Asmar L; Messing MJ; Street DG; Pippitt CH; Bailey CL; Savage J; Young JA
Gynecol Oncol; 2004 Aug; 94(2):533-9. PubMed ID: 15297200
[TBL] [Abstract][Full Text] [Related]
11. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.
Fader AN; von Gruenigen V; Gibbons H; Abushahin F; Starks D; Markman M; Belinson J; Rose P
Gynecol Oncol; 2008 Apr; 109(1):33-8. PubMed ID: 18261784
[TBL] [Abstract][Full Text] [Related]
12. The encouraging prognosis of nongestational ovarian choriocarcinoma with lung metastases.
Liu Y; Yang J; Ren T; Zhao J; Feng F; Wan X; Xiang Y
J Reprod Med; 2014; 59(5-6):221-6. PubMed ID: 24937961
[TBL] [Abstract][Full Text] [Related]
13. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
14. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Fountzilas G; Aravantinos G; Kalofonos C; Efstathiou H; Farmakis D; Skarlos D; Pavlidis N; Economopoulos T; Dimopoulos MA
Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
[TBL] [Abstract][Full Text] [Related]
15. [A case of ovarian cancer stage IV and advanced rectal cancer responding to paclitaxel/carboplatin].
Kawaguchi R; Furukawa N; Morimoto Y; Ohi M; Osawa T; Koike H; Miyake T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):619-22. PubMed ID: 15114712
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment of primary peritoneal carcinoma with paclitaxel and carboplatin combination chemotherapy].
Tohya T; Ujioka T; Yamaguchi M
Gan To Kagaku Ryoho; 2008 Jan; 35(1):153-5. PubMed ID: 18195548
[TBL] [Abstract][Full Text] [Related]
17. Primary peritoneal carcinoma in a young woman with suspected endometriosis.
Banz C; von Otte S; Noack F; Diedrich K; Hornung D
Fertil Steril; 2009 Jul; 92(1):390.e5-7. PubMed ID: 19327764
[TBL] [Abstract][Full Text] [Related]
18. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with cytoreducibility among women with ovarian carcinoma.
Eltabbakh GH; Mount SL; Beatty B; Simmons-Arnold L; Cooper K; Morgan A
Gynecol Oncol; 2004 Nov; 95(2):377-83. PubMed ID: 15491760
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.
Rose PG; Greer BE; Horowitz IR; Markman M; Fusco N
Gynecol Oncol; 2007 Jan; 104(1):114-9. PubMed ID: 16959305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
